Skip to content
healthcare.dev

BENDAMUSTINE HYDROCHLORIDE

NDC 10019-079, bendamustine hydrochloride, injection, from Baxter Healthcare Corporation.

Product NDC
10019-079
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216078
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10019-079 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENDAMUSTINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
10019-079-01100190079011 VIAL, MULTI-DOSE in 1 CARTON (10019-079-01) / 1 INJECTION in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/766b73e2-49bb-47f9-bbb1-44cfa1a3197e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=10019-079

Use it

Look up 10019-079 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10019-079 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10019-079. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.